Selective cyclooxygenase-2 (COX-2) inhibitors are promising anti-inflammatory drugs with potential antitumor activities. The nuclear factor-kappa B (NF-jB) family of proteins is important transcriptional regulators of genes involved in immunity, inflammation, and carcinogenesis. In the present study, we investigated whether and by which molecular mechanism the selective COX-2 inhibitors inhibit NF-jB activation in gastric cancer. The effects of SC236 and its derivative, but devoid of COX-2 enzyme inhibition activity on NF-jB signaling, were evaluated using electromobility shift, transfection, and reporter gene assay. The translocation of RelA/p65 was investigated using Western blotting and immunocytochemistry. We showed that SC236 suppressed NF-jB-mediated gene transcription and binding activity in gastric cancer. This effect occurred through a mechanism independent of cyclooxygenase activity and prostaglandin synthesis. Furthermore, unlike aspirin, SC236 affected neither the phosphorylation, degradation, nor expression of IjB-a, suggesting that the effects of SC236 are independent of IKK activity and IjB-a gene transcription. Instead, SC236 worked directly through suppressing nuclear translocation of RelA/p65. It is possible that SC236 directly targets proteins that facilitate the nuclear translocation of NF-jB. Our study suggests an important molecular mechanism by which COX-2 inhibitors reduce inflammation and suppress carcinogenesis in gastrointestinal tract.
Introduction
The recently developed cyclooxygenase-2 (COX-2) inhibitors have received great attention because of their protective effects against digestive cancers and their superior safety profile comparing with the classical nonsteroidal anti-inflammatory drugs (NSAIDs) (DuBois et al., 1996; Gupta et al., 1998) . For instance, COX-2 inhibitors have been shown to inhibit proliferation of colon cancer cell and inhibit the formation of colorectal cancers in animal models through induction of apoptosis (Reddy et al., 1996; Sheng et al., 1998; Richter et al., 2001) . Besides colorectal cancers, COX-2 inhibitors also suppress tumor growth in nude mice bearing gastric cancer xenografts by induction of apoptosis (Sawaoka et al., 1998) . In accordance with these studies, our group demonstrated that a COX-2 inhibitor SC236 (12.5-50 mm) exhibited antitumor effect by induction of apoptosis in gastric cancer cells (Jiang et al., 2002) . While the efficacy of this class of drugs has been effectively demonstrated, their mechanism of action is still far from clear. Their primary cellular target has been assumed to be the inducible cyclooxygenase isoenzyme COX-2 (Vane, 1971) .
Overexpression of COX-2 has been observed in many tumors (Kargman et al., 1995; Parett et al., 1997; Ristimaki et al., 1997) , and prostaglandins also contribute to tumor growth by inhibiting apoptosis (Sheng et al., 1998) and inducing the formation of new blood vessels within tumors (Masferer et al., 2000) . Although inhibition of COX-2 and subsequent decrease in prostaglandin production may contribute to the anticancer effect of NSAIDs, COX-2 may not be the only target of NSAIDs. For example, NSAIDs might regulate nuclear factor-kappa B (NF-kB) signaling, cytochrome c, Akt (protein kinase B) protein kinase C, or peroxisome proliferator-activated receptor d (PPARd) (He et al., 1999; Hsu et al., 2000; Weber et al., 2000; Zhu et al., 2000) when given at high doses. Also at high concentrations, NSAIDs have antiproliferative and proapoptotic effects on tumor cells that do not express COX-2 (Hanif et al., 1996; Elder et al., 1997; Grosch et al., 2001) . Therefore, it appears that NSAIDs have other possible molecular targets besides COX-2.
The NF-kB family of proteins are important transcriptional regulators of genes involved in immunity, inflammation, and carcinogenesis (Wulczyn et al., 1996; Barnes et al., 1997) . Recently, the NF-kB pathway has also been found to be critical in the control of cellular growth and apoptosis (Beg et al., 1995; Chu et al., 1997; Wang et al., 1998) . NF-kB is normally sequestered in the cytoplasm of cells where it is bound by a family of inhibitory proteins known as IkB (Barnes et al., 1997) . A variety of stimuli including TNF, interleukin-1, phorbol esters, and lipopolysaccharide modulate signal transduction pathways including NIK and MEKK1 to activate the IkB kinases IKKa and IKKb. Stimulation of the activity of these kinases results in phosphorylation, ubiquitination, and degradation of IkB, leading to the nuclear translocation of NF-kB (Baldwin, 1996) . Aspirin and sodium salicylate, but not several other anti-inflammatory agents including indomethacin, can inhibit activation of the NF-kB pathway (Kopp et al., 1994; Grilli et al., 1996; Wahl et al., 1998; Yin et al., 1998; Yamamoto et al., 1999) . Inhibition of the NF-kB pathway by aspirin and salicylate is the result of their specific binding to IKK, prevention of IkBa degradation, and nuclear translocation of NF-kB. Furthermore, inhibition of NF-kB activity contributes at least in part to the anti-inflammatory and antitumor effect of NSAIDs (Grilli et al., 1996; Yamamoto et al., 1999) .
In the present study, we show that a COX-2 inhibitor SC236 has potent anti-NF-kB effects in gastric cancer. This effect is not related to the inhibition of COX-2 activity. Furthermore, we show that unlike aspirin, SC236 does not prevent phorbol-12-myristate-13-acetate (PMA)-inducible IkB-a degradation. In contrast, SC236 inhibits NF-kB-mediated transcription activity through blocking the translocation of RelA/p65 protein from cytosol to the nucleus. This report demonstrates molecular mechanisms of COX-2 inhibitor in suppressing NF-kB activation, which may play an important role in its anti-inflammation and antitumour properties.
Results

SC236 and aspirin inhibit NF-kB-mediated transcriptional activity in gastric cancer
To determine whether SC236 is an inhibitor of NF-kBmediated gene transcription, human gastric cancer cells, AGS and MKN28, were transiently cotransfected with the kB-luciferase reporter plasmid and the pRL-CMV vector. Transfected cells were firstly incubated with different concentrations of SC236 for 2 h, and then transferred into the media in the presence of 200 nm PMA or 50 ng/ml TNF-a for an additional 12 h. Our data (Figure 1a, b) showed that SC236 inhibited PMA or TNF-a-stimulated NF-kB-mediated transcription activity in both AGS and MKN28 cells in a dosedependent manner. The magnitudes of the SC236-induced decrements were similar in both cell lines, with MKN28 cells being slightly more responsive. The IC 50 for SC236 in AGS and MKN28 cells were approximately 40/50 and 25/30 mm in inhibiting the PMA/TNFa-stimulated NF-kB-mediated transcription activity, respectively. To further confirm the specificity of the inhibition effect by SC236, we demonstrated that SC236 did not significantly affect the transcription activity of the pRL-CMV or pRL-SV40 (Promega, Madison, WI, USA) (data not shown). As conventional NSAIDs can also inhibit NF-kB-mediated transcription, we compared the effect of aspirin on NF-kB-mediated gene transcription in both cell lines. Aspirin inhibited NF-kBmediated gene transcription in a dose-dependent manner (Figure 1c, d) , with IC 50 approximately equal to 2.5/ 2.5 and 2.5/3 mm for PMA/TNF-a-stimulated NF-kB transcriptional activity in both AGS and MKN-28 cells.
SC288 inhibited PMA-and TNF-a-induced activation of NF-kB in gastric cancer cells
To determine whether the inhibition of NF-kB activity is related to COX activity, we used a compound SC288, which is a derivative of SC-236 but devoid of COX enzyme inhibition effect. To confirm the COX-2 inhibition effect by SC236 and SC288, we first determined whether SC-236 and SC288 inhibited the PGE 2 production in gastric cancer cells. As ELISA assay showed (Figure 2a, b) , PGE 2 production was significantly inhibited with IC 50 equal to about 1 mm in AGS and 3 mm in MKN-28 cells. However, SC288 had no effect on PGE 2 production in both cell lines. Then we determined the effect on NF-kB transcriptional activity by SC288. As shown in Figure 2c , d, SC288 also inhibited the PMA-or TNF-a-induced NF-kB activation dose dependently in both cell lines. Since both SC236 and SC288 inhibited PMA-induced NF-kB activity in gastric cancer cells, we hypothesized that the inhibition effect does not occur through inhibition of COX-2. 
SC236 does not inhibit PMA-induced phosphorylation and degradation of IkB-a
To determine whether SC236 caused IkB-a degradation, we measured the level of total IkB-a by Western blot analysis after treating cells with either 200 nm PMA alone or PMA in the presence of 50 mm SC236. As shown in Figure 4a , PMA treatment reduced the expression of IkB-a protein in both AGS and MKN-28 cells. The reduction was detectable as early as 15 min after PMA treatment. Addition of SC236 had no effect on PMA-induced reduction in IkB-a protein level. We further determined whether SC236 had any effect on IkB-a phosphorylation. As shown in Figure 4b , a 30-min PMA treatment effectively caused a significant induction of IkB-a phosphorylation in both AGS and MKN28 cells. SC236 had no effect on IkB-a phosphorylation in cells treated with PMA.
For comparison, we also tested the effect of aspirin in AGS cells. We showed that PMA (200 nm) treatment induced IkB-a phosphorylation and aspirin (5 mm) significantly inhibited PMA-induced IkB-a phosphorylation as indicated by a reduced level of phospho-IkB-a ( Figure 4c ). Consistent with an increased IkB-a phosphorylation, PMA treatment alone reduced the level of IkB-a, which is inhibited by aspirin ( Figure 4c ).
SC236 inhibits PMA-stimulated nuclear translocation of the RelA/p65 subunit of NF-kB Since NF-kB activation requires nuclear translocation of RelA/p65 subunit of NF-kB, we examined the effect of SC236 on the cytosolic and nuclear pool of RelA/p65 protein by Western blot analysis in both AGS and MKN28 cells (Figure 5a ). We showed that PMA treatment effectively increased the nuclear RelA/p65 protein level and decreased the cytosolic RelA/p65 pool, which is an indication of the nuclear translocation of RelA/p65. Addition of SC236 significantly inhibited the PMA-stimulated increase and decrease of the nuclear and cytosolic RelA/p65 levels, respectively, in both cell lines. These results suggest that SC236 blocks the nuclear translocation of the RelA/p65 from cytosol.
To confirm this result, nuclear translocation of p65 subunits of NF-kB in AGS cells was visualized using immunofluorescent confocal microscopy. Before PMA 
SC236 inhibited PMA-induced phosphorylation and degradation of I kB-a in colon cancer cell lines
Studies indicate that NSAID-mediated regulation of NF-kB pathway may be cell-type specific (Stark et al., 2001) . Therefore, we wanted to determine whether other cancer cell lines also responded to SC236 with similar effect on the NF-kB pathway. In two colon cancer cell lines (SW1116, colo205) tested, 50 mm SC236 significantly inhibited PMA-stimulated IkB-a phosphorylation and degradation (Figure 6a ). Furthermore, Western blot analysis also showed that SC236 suppressed PMA-stimulated p65/RelA translocation from cytoplasm to nuclear in these two cell lines (Figure 6b ). These results suggest that SC236 regulates NF-kB pathway through different mechanisms in the different cell system.
Discussion
SC236 has been shown to inhibit various tumor growth through induction of apoptosis (Richter et al., 2001; Connolly et al., 2002; Jiang et al., 2002) . Our group previously showed that SC236 inhibited COX-2 activity with IC 50 equal to 1 mm in gastric cancer cells, whereas its derivative SC288 did not have this effect (Jiang et al., 2002) . We also demonstrated that high doses of SC236 (12.5-50 mm) suppressed cell growth and induced apoptosis in gastric cancer, which suggest that the antitumor effect of SC236 is independent of COX-2 enzyme inhibition ( activation plays a pivotal role in both the pathogenesis of the inflammatory response and in cellular growth control, we investigate the possible usefulness of SC236 in its inhibitory effect on NF-kB activity in gastric cancer cells in the present study. Based on the findings that the same range of SC236 (10-50 mm) suppresses PMA/TNF-a-induced NF-kB DNA binding and NF-kB transactivation in gastric cancer cells, we hypothesize that the anti-inflammatory and antitumor effects of SC236 are due, at least in part, to the suppression of NF-kB activity. Furthermore, we also show that SC288, which is derived from SC236 but lacks COX-2 enzyme inhibition activity, also inhibits NF-kB activation dose dependently. This result indicates that the inhibitory effect of SC236 on NF-kB activation in gastric cancer is independent of the activity and specificity of the compound towards COX-2 isoenzyme and non-COX mechanisms may be involved in the anti-inflammatory and antineoplastic effects of NSAIDs (Zhou et al., 2001; Zhu et al., 1999 Zhu et al., , 2000 .
NF-kB transcription factors are regulated primarily by the interaction with inhibitor IkB proteins. Most agents that activate NF-kB do so through a common pathway, which is based on the phosphorylationinduced, proteasome-mediated proteolysis of IkB. Most of the inhibitors of NF-kB activation, including NASIDs, mediate their effects through suppressing IkB-a phosphorylation and degradation (Kopp et al., 1994; Yin et al., 1998; Yamamoto et al., 1999) . For example, when cells were stimulated with lipopolysaccharides (LPS) in the presence of sodium salicylate or aspirin, the LPS-induced proteolysis of IkB-a was abolished, which suggests that the observed NF-kB inhibition was mediated through inhibition of the phosphorylation and/or the subsequent proteasome cleavage of IkB-a (Kopp et al., 1994) . However, some new compounds have been shown to modulate the transcriptional activity of NF-kB by mechanisms other than the cytosolic sequestration of IkB. Among the NSAIDs found to inhibit NF-kB, R-flurbiprofen affected neither the phosphorylation, degradation, nor expression of IkB, suggesting that the effects of Rflurbiprofen were independent of IkB gene transcription . In this study, we showed that SC236 acted through a mechanism different from that of aspirin in gastric cancer. Unlike aspirin, SC236 inhibited NF-kB activity by blocking the RelA/p65 translocation to the nucleus without significant effect on phosphorylation and degradation of IkB-a. This effect on RelA/ p65 has also been observed in some other compounds. For example, caffeic acid phenethyl ester inhibited the translocation of RelA/p65 by phosphorylation (Natarajan et al., 1996) . Resveratrol blocked TNF-a stimulated RelA/p65 translocation to the nucleus, but had no effect on the binding of NF-kB protein to the DNA (Manna et al., 2000) .
The pathways that transduce the signal from the activated receptor that culminate in phosphorylation and degradation of IkB-a are incompletely characterized. However, the key regulatory step in this pathway involves activation of an IKK complex. A mitogenactivated protein kinase kinase kinase called NIK initiates the phosphorylation and activation of IKKa and b and the IKK a/b heterodimer directly phosphorylates IkB-a and IkB-b on N-terminal serine residues. It was shown that aspirin could directly bind to and inhibit the kinase activity of IKK-b by reducing its ability to bind ATP (Yin et al., 1998) . However, we showed that Rather, a kinase with specificity for RelA/p65 and not IkB is implicated. On the other hand, recent studies from IKKaÀ/À and IKKbÀ/À mice show that in IKKbÀ/À mice, the IL-1-initiated NF-kB response is only partially inhibited (Mercurio et al., 1999) , which indicates that an IKKa/b independent kinase that phosphorylates IkB polypeptides may be activated. Such kinases may exhibit overlapping but preferential interactions with IkB and RelA/p65 substrates. SC236 may selectively inhibit a kinase that preferentially interacts with RelA/p65 without inhibiting another kinase that preferentially interacts with IkB polypeptides. A recent study demonstrated that aspirin activated NF-kB in colon cancer cell lines by increasing the phosphorylation and subsequent degradation of IkB, which was associated with induction of apoptosis (Stark et al., 2001) . In contrast, aspirin had no effect on IkB-a in embryonic kidney (293) or in lung adenocarcinoma (A549) cells, suggesting that the activation of NF-kB by aspirin is cell-type specific. In the present study, we showed that SC236 inhibited NF-kB activation in SW1116 and colo205 colon cancer cell lines. However, this effect is through suppression of IkB-a degradation and RelA/p65 translocation. These results indicate that SC236 inhibits NF-kB activity through different pathways, possibly depending on the cell type and stimulus involved. Our results provide a novel mechanism by which NSAIDs regulate NF-kB activation in gastric cancer.
In summary, we have provided evidence for a novel mechanism of the antitumor and anti-inflammatory effect of COX-2 inhibitor. Our data showed that SC236 inhibited NF-kB transcriptional and binding activity by preventing the translocation of RelA/p65 from cytosol to the nucleus. These results may provide insight regarding the molecular basis for the development of new chemoprotective agents against gastric cancer.
Materials and methods
Reagents
We investigated the potential of 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-l-yl]benzenesulfonamide (SC236), a selective COX-2 inhibitor (Penning et al., 1997) , and SC288 (SC236 derivative but devoid of COX-2 enzyme inhibition activity) (supplied by Searle, IL, USA) in this study. Antibodies against specific phospho-IkBa(Ser32/36) and IkB-a were purchased from New England Biolabs (Boston, MA, USA). Antibody against the RelA/p65 subunit of NF-kB was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). PMA and TNF-a were purchased from Calbiochem (La Jolla, CA, USA). Unless otherwise stated, the rest of the reagents were purchased from Sigma (CA, USA).
Cell culture conditions
Human gastric cancer cell line AGS was purchased from American Type Culture Collection (ATCC, Rockville, MD, USA). Human gastric cancer cell line MKN28 was purchased Human colon cancer cell line SW1116 and colo205 were purchased from ATCC (Rockville, MD, USA). Cells were maintained in an RPMI1640 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin in a humidified 5% CO 2 , and 95% air incubator at 371C.
Transient transfection and NF-kB reporter gene assay
A NF-kB luciferase reporter plasmid containing IL-6 promoter region with four repeats of NF-kB binding sites was used to measure NF-kB-mediated transcriptional activity (Li et al., 1997 
Preparation of cytoplasmic and nuclear extract
Nuclear and cytoplasmic extracts were prepared as described by Dignam et al. (1983) . Confluent cells in 10-cm dishes were treated for various times with the indicated effectors. Cells were then washed two times with ice-cold phosphate-buffered saline (PBS) and resuspended in 400 ml of buffer A (containing 10 mm HEPES at pH 7.9, 1.5 mm MgCl 2 , 10 mm KCl, 0.5 mm DTT, 0.5 mm PMSF, 1 mg/ml leupeptin, 1 mg/ml aprotinin, and 1 mg/ml pepstatin A). The cells were allowed to swell on ice for 15 min, lysed gently with 12.5 ml of 10% Nonide P-40, and centrifuged at 2000 g for 10 min at 41C. The supernatant was collected and used as the cytoplasmic extracts. The nuclei pellet was resuspended in 40 ml of buffer C (20 mm HEPES, pH 7.9, containing 1.5 mm MgCl 2 , 450 mm NaCl, 25% glycerol, 0.2 mm EDTA, 0.5 mm DTT, 0.5 mm PMSF, 1 mg/ml leupeptin, 1 mg/ml aprotinin, 1 mg/ml pepstatin A), agitated for 30 min at 41C, and the nuclear debris was spun down at 20000 g for 15 min. The supernatant (nuclear extract) was collected, frozen in liquid nitrogen and stored at À801C until ready for analysis. Protein concentration was determined using Bradford reagent.
Western blot analysis
A measure of 20 mg of protein was resolved and separated by electrophoresis on a 10% denaturing protein gel. Proteins were electroblotted onto nitrocellulose membranes. Detection of phospho-IkB-a, IkB-a (New England Biolabs), and RelA(p65) (Santa Cruz) was conducted by immunostaining using their specific antibodies (at 1 : 500 dilution) and horseradish peroxidase-conjugated anti-IgG antibody (Santa Cruz). The protein bands were visualized by the enhanced chemiluminesence (ECL) assay (Amersham Pharmacia Biotech, NJ, USA) following the manufacturer's instructions.
Electrophoretic mobility shift assay
A total of 8 mg of nuclear proteins was incubated with 1 mg each of poly (dI.dC) in the presence of 30 fmol of Digoxin(DIG)-labeled double-stranded NF-kB probe (5 0 -AGT TGA GGG GAC TTT CCC AGG C -3 0 Santa Cruz) for 15 min at room temperature in a total volume of 20 ml using DIG gel shift kit (Roche Diagnostics GmbH, Mannheim, Germany). Oligonucleotide competition experiments were performed in the presence of 50-fold excess of unlabeled NF-kB oligos. DNA complexes were resolved from free probe with 4% nondenaturing polyacrylamide gels in 0.5 Â Tris-borate-EDTA (pH 8.3) and visualized by fluorography.
Immunocytochemistry and confocal microscopy AGS cells were fixed with 3% paraformaldehyde and were permeabilized with ice-cold 80% methanol. After incubation with 3% skimmed milk in PBS for 60 min, the preparation was incubated for 1 h at room temperature with the RelA/p65 antibody diluted in 0.1% bovine serum albumin (BSA, 1 : 50). The preparation was next washed three times with PBS and was then exposed to the secondary antibody (fluorescein isothiocyanate-conjugated anti-rabbit IgG at 1 : 100 and 0.1% BSA/PBS, Pierce Chemicals, Rockford, USA) for 60 min. The fluorescent image was viewed with a Zeiss LSM-410 laser scanning microscope (Zeiss, Oberkochen, Germany).
